Dotmatics Signs Definitive Agreement to be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences
- Siemens AG will acquire Dotmatics, a U.S.-based R&D software company, for $5.1 billion.
- Siemens is acquiring Dotmatics from Insight Partners to strategically strengthen its position in Life Sciences.
- Dotmatics, founded in 2005, serves over two million scientists with its cloud-based platform that streamlines data and workflows.
- CEO Roland Busch stated the acquisition strengthens Siemens' Life Sciences position, creating an AI-powered PLM software portfolio.
- Siemens expects revenue synergies, with Dotmatics projected to generate over $300 million in revenue in 2025, enhancing Siemens' digital capabilities.
53 Articles
53 Articles
Siemens continues its industrial software purchasing tour by buying the US software company Dotmatics for 5.1 billion dollars. The acquisition is intended to strengthen Siemens' position in the pharmaceutical industry and drive the growth program ‘One Tech Company'.
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
Germany group Siemens said on Wednesday it is buying Dotmatics, a US software company, for $5.1 billion to leverage its use of artificial intelligence to make drug discoveries. Siemens said the acquisition was "complementary" to its expansion into Life Sciences and would lift its game in a market needing more medication innovation as populations age. "These trends underscore the need for digital transformation, with software spending expected to…
“Artificial intelligence has emerged as a transformative force in several industries, and its application in the life sciences is becoming increasingly important,” says CEO, Roland Busch
Siemens is intensifying in the field of research and development. A lot of money is spent on a US company.
Channel News Asia
The Globe & MailSiemens to acquire Dotmatics in $5.1 billion deal in Life Science portfolio push
Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio. Financing for the deal would be primarily carried by share sales of listed companies, including healthcare subsidiary Siemens Healthineers, it
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
